Mendus to participate in upcoming conferences in April 2023 and to hold investor call following Annual Report publication on April 17th
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
OKSPOT Unveils Privacy-Focused Crypto Exchange for Global Traders With No-KYC Registration and Monero Support
Mambu and Mastercard expand cross-border payment capabilities for banks across APAC
Indonesia’s ITS Celebrates 66th Anniversary and Officially Closes KSTI 2026
Shaping the Future Together: Voices from Around the World at the III International Symposium ‘Creating the Future’ in Russia
The UAE’s AI Adoption Is a World Record. Paying for It Is Another Story